International Consensus Conference on Atopic Dermatitis II (ICCAD II): clinical update and current treatment strategies. - Wikidata - wikimedia - TriplyDB

International Consensus Conference on Atopic Dermatitis II (ICCAD II): clinical update and current treatment strategies.

International Consensus Conference on Atopic Dermatitis II (ICCAD II): clinical update and current treatment strategies.

http://www.wikidata.org/entity/Q35106685

about

Topical pimecrolimus for eczema An Alternative Approach to Atopic Dermatitis: Part II—Summary of Cases and Discussion A pilot study showing pulsed-dye laser treatment improves localized areas of chronic atopic dermatitis.Mycophenolate mofetil for severe childhood atopic dermatitis: experience in 14 patients.Dexamethasone and FK506 inhibit expression of distinct subsets of chemokines in human mast cells The Traditional Chinese Medicine and Relevant Treatment for the Efficacy and Safety of Atopic Dermatitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.The effects of treatment on itch in atopic dermatitis Age related, structured educational programmes for the management of atopic dermatitis in children and adolescents: multicentre, randomised controlled trial.Efficacy and Tolerability of Steroid-Free, Over-the-Counter Treatment Formulations in Infants and Children With Atopic Dermatitis A pilot study of emollient therapy for the primary prevention of atopic dermatitis Stem cell treatment for patients with autoimmune disease by systemic infusion of culture-expanded autologous adipose tissue derived mesenchymal stem cells.Effect of bathing on atopic dermatitis during the summer season.Topical tacrolimus in the management of atopic dermatitis in Japan.Exploring the use of emollient therapy in dermatological nursing.Refractory atopic dermatitis in childhood: improvement with methotrexate?Cyclosporin in the treatment of patients with atopic eczema - a systematic review and meta-analysis.Safety of topical calcineurin inhibitors for the treatment of atopic dermatitis.The role of pimecrolimus cream 1% (Elidel)) in managing adult atopic eczema.Care or harm: exploring essential components in skin care regimens.Quantitative assessment of combination bathing and moisturizing regimens on skin hydration in atopic dermatitis.Atopic dermatitis and the atopic march: what is new?House dust mite reduction in the management of atopic dermatitis. A critically appraised topic.Atopic dermatitis burden scale: creation of a specific burden questionnaire for families.Pimecrolimus, a topical calcineurin inhibitor used in the treatment of atopic eczema.Efficacy of kampo medicine in treating atopic dermatitis: an overview.Are baths desirable in atopic dermatitis?Mediators of Chronic Pruritus in Atopic Dermatitis: Getting the Itch Out?Objective evaluation for severity of atopic dermatitis by morphologic study of skin surface contours.Clinical Practice Guidelines for the Management of Atopic Dermatitis 2016.Bathing and Associated Treatments in Atopic Dermatitis.Patient-reported outcomes from a multicenter, randomized, vehicle-controlled clinical study of MAS063DP (Atopiclair) in the management of mild-to-moderate atopic dermatitis in adults.Efficacy and Safety of a Traditional Herbal Medicine, Hochu-ekki-to in the Long-term Management of Kikyo (Delicate Constitution) Patients with Atopic Dermatitis: A 6-month, Multicenter, Double-blind, Randomized, Placebo-controlled Study.Management of patients with atopic dermatitis: the role of emollient therapy.Care or harm: exploring essential components in skin care regimens.Breastfeeding and mucosal and cutaneous colonization by Staphylococcus aureus in atopic children.A comparison of the leaf gel extracts of Aloe ferox and Aloe vera in the topical treatment of atopic dermatitis in Balb/c mice.Treatment of atopic dermatitis with a combination of allergen-specific immunotherapy and a histamine-immunoglobulin complex.Diagnosis and management of common dermatoses in children: atopic, seborrheic, and contact dermatitis.Treatment of Atopic Dermatitis From the Perspective of Traditional Persian Medicine: Presentation of a Novel Therapeutic Approach.Economic assessment of actual prescription of drugs for treatment of atopic dermatitis: Differences between dermatology and pediatrics in large-scale receipt data.

P2860

Q24243250-E8C11399-E35B-40C9-84D5-0CE4A15C793E Q24806074-7E1F0F35-F3CC-4912-A700-0AD5B8E69257 Q33315158-9034C3D8-94A8-40A9-B250-0EC3C59DBBB0 Q33375192-A61B5581-D0A5-46CB-9F7B-ABB06195A836 Q33669494-30D2E0B6-A5D0-44DE-8B8B-9056F9850995 Q33872732-C2D42904-A4AB-4354-B590-9C312754256E Q34336696-4CE70299-81CD-41D6-AC62-E8F80D4B4E87 Q34557064-9C1CBA10-EAB7-468C-B7EF-E52FCAD71C62 Q35054228-5D68BD92-934F-4397-AC6D-600A50201B9F Q35166369-DAED35CE-0F95-48B1-99A2-186843B964D4 Q35568777-9E40B75A-35F4-44ED-8C2A-405631E1278F Q36365187-0ED538D6-0EAC-4853-AD7B-BBE57F3C0434 Q36466798-4797C4AA-35B8-404B-A6CD-4D7A32A24B5C Q36488634-CB62442D-8041-415E-9113-698B7A10941B Q36640489-07155048-478F-4D2D-BB4B-16FF5E51C547 Q36797258-F3F79554-D57C-489C-9503-BB0287EA24FD Q36861654-E195ABBB-F1D0-45C6-A498-69A28144E5A9 Q37049986-A6D705C5-BAF4-475C-A619-45F67775F9F4 Q37133055-C414600D-FCF1-4BBD-AE60-52220BBE3458 Q37388512-34889A5C-CB51-40FE-8310-313E8B40B3F4 Q37937455-27A0D55F-5107-43D0-B153-68893090B053 Q38092907-8F5EDB18-489C-4328-A47E-71F75AA33667 Q38107026-3195966A-E31D-479F-9485-0D3FB3429C9C Q38123240-9857F944-CB4C-4D31-8B5C-1DDF2AECA7E9 Q38196809-7634DB15-720B-4C18-ABAF-FCEA3342D5FF Q38334615-47C93DF3-ABA4-4056-803E-17012059658C Q38452688-19612A30-D16F-4A1C-8BEC-4499574B0860 Q38512697-63F2E152-87C0-4BEC-9DD2-B94273F2FCD6 Q38807878-ECA08E87-EDCC-4DD3-A80E-18F6F1C038F9 Q39028153-7861FE6C-EA0E-4E02-BC95-2818DD09E6D1 Q39315300-DE881300-5E54-46DD-86C9-5E7CA04C5669 Q41137745-6027511A-C3F1-47F8-AD35-59D96ACF31A0 Q41774269-5CB01413-AEC4-44CA-A433-2F0CB5AC653E Q42981141-A677D31F-C03C-49F6-BF0C-9288C1B7F3EC Q43331531-BA223971-AF35-4B17-9D23-DB6BAC3C6FDC Q46610735-26F79490-B646-4CFC-A9DB-C5484FF9BE4D Q46758748-1D37A890-8FFC-4F43-8652-2A209DC75D84 Q46868092-383956C9-8A40-43D9-BAB0-1072A9239A4B Q47388285-39A2A786-551F-402F-A08E-443939A0BCD6 Q47424936-A578DCB1-377B-46FD-97ED-C73AB328FA2A

P2860

International Consensus Conference on Atopic Dermatitis II (ICCAD II): clinical update and current treatment strategies.

http://www.wikidata.org/entity/Q35106685

description

2003 nî lūn-bûn

@nan

2003 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

International Consensus Confer ...... current treatment strategies.

@ast

International Consensus Confer ...... current treatment strategies.

@en

type

label

International Consensus Confer ...... current treatment strategies.

@ast

International Consensus Confer ...... current treatment strategies.

@en

prefLabel

International Consensus Confer ...... current treatment strategies.

@ast

International Consensus Confer ...... current treatment strategies.

@en

P1433

Q35106685-082C80AB-5F8D-426A-AD55-2AD57527B3FF

P1476

Q35106685-F5E149C0-C0DC-463A-B7B5-EF110084606F

P2093

Q35106685-1545B74E-A7F6-43F8-B7C9-8B72FBBA5E49

Q35106685-17942E32-C254-4302-974F-CF00D7AEDD8C

Q35106685-3D712685-4C00-46DA-B3B0-05A78C4E7690

Q35106685-44FB40AA-3502-4CC2-970F-92B9DA7C790F

Q35106685-520CCE72-E357-497D-BD51-A7B4D968D4DC

Q35106685-55084712-DC14-495B-A451-2B00F1CC0E40

Q35106685-5698D0C6-FE95-47F8-838C-7C378A393658

Q35106685-600B2F68-A92D-4117-A2A5-F9A880DD8840

Q35106685-61DB6413-9ADA-499B-B1BF-0E69B1CCC505

Q35106685-6C9048F8-B81F-40CF-9BFD-E1679E9E4EAB

P2860

Q35106685-2684E2CA-8945-44C9-A411-5D92F4FCBA4B

Q35106685-2FCBD6AD-42BD-4010-A4E0-44F936FA0B3E

Q35106685-33D7793E-198B-465B-A674-4A3D24695B62

Q35106685-35AC1AB8-44AD-42E0-AF76-01C2DE67B8E5

Q35106685-35B2BF73-10AE-4CEF-841E-445454E6A97E

Q35106685-363A74B0-9B59-4D53-9693-359D3DA7933B

Q35106685-421A8552-AD68-4E4E-BE93-9275CCE29D0C

Q35106685-4AC8D978-304B-4772-9318-1A8CC46E9D72

Q35106685-4FD05D27-5268-4D5E-9EF2-64C7138D73C9

Q35106685-5BFB2D3F-9A8D-412B-942E-C55A2AE4886D

P304

Q35106685-FE2AEE57-6B97-4652-B045-A278DC38ABA2

P31

Q35106685-1E5D07E3-1F24-46FA-9036-5CD6F284BC4C

P356

Q35106685-ADC5ACFA-8C79-49BE-B69A-0D3839E39FC2

P407

Q35106685-58809507-AF17-432F-BBAD-D470A448955B

P478

Q35106685-939FBB4B-0EF4-499D-8AA7-F655B915D6C4

P577

Q35106685-D602DA35-8F4D-471E-B4A8-4A0D27050622

P5875

Q35106685-CA0D9560-75DD-434F-8042-5328A15D9EED

P698

Q35106685-EEE9DD6D-54A1-4DEF-B7E8-40AD7770C7A3

P356

J.1365-2133.148.S63.1.X

P1433

British Journal of Dermatology

P1476

International Consensus Confer ...... current treatment strategies.

@en

P2093

A Giannetti

http://www.w3.org/2001/XMLSchema#string

C Ellis

http://www.w3.org/2001/XMLSchema#string

C Ferrandiz

http://www.w3.org/2001/XMLSchema#string

C Lynde

http://www.w3.org/2001/XMLSchema#string

D Abeck

http://www.w3.org/2001/XMLSchema#string

D Leung

http://www.w3.org/2001/XMLSchema#string

ICCAD II Faculty

http://www.w3.org/2001/XMLSchema#string

J Hanifin

http://www.w3.org/2001/XMLSchema#string

J Ring

http://www.w3.org/2001/XMLSchema#string

J Y M Koo

http://www.w3.org/2001/XMLSchema#string

P2860

A novel anti-inflammatory drug, SDZ ASM 981, for the treatment of skin diseases: in vitro pharmacology

Use of nonsteroidal topical immunomodulators for the treatment of atopic dermatitis in the pediatric population.

Systemic therapy of atopic dermatitis.

Cellular and immunologic mechanisms in atopic dermatitis.

Current management and therapy of atopic dermatitis.

Long-term management of atopic dermatitis in infants with topical pimecrolimus, a nonsteroid anti-inflammatory drug.

A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group.

Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents.

Severity distribution of atopic dermatitis in the community and its relationship to secondary referral.

Safety and efficacy of nonsteroid pimecrolimus cream 1% in the treatment of atopic dermatitis in infants.

P304

3-10

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1365-2133.148.S63.1.X

http://www.w3.org/2001/XMLSchema#string

P407

P478

148 Suppl 63

http://www.w3.org/2001/XMLSchema#string

P577

2003-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10806231

http://www.w3.org/2001/XMLSchema#string

P698

12694268

http://www.w3.org/2001/XMLSchema#string